Enorama Pharma AB (publ) (STO:ERMA)
0.3840
-0.0190 (-4.71%)
Apr 14, 2026, 10:15 AM CET
Enorama Pharma AB Market Cap
Enorama Pharma AB has a market cap or net worth of 28.64 million as of April 14, 2026. Its market cap has decreased by -79.50% in one year.
Market Cap
28.64M
Enterprise Value
25.61M
Revenue
2.74M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.38
Market Cap Chart
Since June 10, 2016, Enorama Pharma AB's market cap has decreased from 35.83M to 28.64M, a decrease of -20.05%. That is a compound annual growth rate of -2.25%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 13, 2026 | 30.06M | -78.90% |
| Dec 30, 2025 | 142.46M | -29.89% |
| Dec 30, 2024 | 203.19M | 77.51% |
| Dec 29, 2023 | 114.47M | 308.04% |
| Dec 30, 2022 | 28.05M | -83.60% |
| Dec 30, 2021 | 171.01M | -12.51% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Jun 10, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| EQL Pharma AB | 1.64B |
| Dicot Pharma AB | 791.28M |
| Cinclus Pharma Holding AB | 765.08M |
| Orexo AB | 731.61M |
| Enzymatica AB | 730.63M |
| Nanexa AB | 641.88M |
| Moberg Pharma AB | 473.77M |
| Klaria Pharma Holding AB (publ.) | 300.09M |